Isoflavones, their glycosides and glycoconjugates. Synthesis and biological activity

Current Organic Chemistry

Volumn 21, Issue 3, 2017, Pages 218-235

  Szeja, Wiesław ^a   Grynkiewicz, Grzegorz ^b   Rusin, Aleksandra ^c  

^a SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^b INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

^c INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Chemical glycosylations; Isoflavone glycoconjugates; Isoflavones

Indexed keywords

FLAVONOIDS; GLYCOSIDES; METABOLITES; MOLECULES; SUGARS;

BIOLOGICALLY ACTIVE MOLECULES; CHEMICAL GLYCOSYLATION; GLYCOCONJUGATES; GLYCOSYLATIONS; ISOFLAVONE GLYCOCONJUGATE; ISOFLAVONES; NUTRACEUTICALS; SECONDARY METABOLITES; THERAPEUTIC AGENTS;

BIOACTIVITY;

EID: 85029522276     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/1385272820666160928120822     Document Type: Review

References (174)

1. Newman, D.J.; Cragg, G.M.; Snader, K.M. The influence of natural products upon drug discovery. Nat. Prod. Rep., 2000, 17, 215-234.
2. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod., 2007, 70, 461-477.
3. Cragg, G.M.; Newman, D.J. Natural products: A continuing source of novel drug leads. Biochim. Biophys. Acta, 2013, 1830, 3670-3695.
4. Tremblay, R.; Wang, D.; Jevnikar, A.M.; Ma, S. Tobacco, a highly efficient green bioreactor for production of therapeutic proteins. Biotechnol. Adv., 2010, 28, 214-221.
5. Yusibov, V.; Streatfield, S.J.; Kushnir, N. Clinical development of plant-produced recombinant pharmaceuticals: Vaccines, antibodies and beyond. Human Vaccines, 2011, 7, 313-321.
6. Zeiner, M.; Cindric, J.I.; Pozgaj, M.; Pirkl, R.; Silic, T.; Stingeder, G. Influence of soil composition on the major, minor and trace metal content of Velebit biomedical plants. J. Pharm. Biomed. Anal., 2015, 106, 153-158.
7. Osbourn, A.E.; Lanzotti, V. Plant-derived Natural Products. Synthesis, Function and Application; Springer-Verlag: Dordrecht, 2009.
8. Lopez Larrea, C. Sensing in Nature; Springer-Verlag: New York, 2012.
9. Moon, Y.J.; Wang, X.; Morris, M.E. Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro, 2006, 20, 187-210.
10. Korkina, L.G. Phenylpropanoids as naturally occurring antioxidants: From plant defense to human health. Cell Mol. Biol. (Noisy-le-grand), 2007, 53, 15-25.
11. Kabera, J.N.; Semana, E.; Mussa, A.R.; He, X. Plant secondary metabolites: Biosynthesis,. classification, function and pharmacological properties. J. Pharm. Pharmacol., 2014, (2), 377-392.
12. Harborne, J.B.; Williams, C.A. Advances in flavonoid research since 1992. Phytochemistry, 2000, 55, 481-504.
13. Martens, S.; Mithofer, A. Flavones and flavone synthases. Phytochemistry, 2005, 66, 2399-2407.
14. Vogt, T. Phenylpropanoid biosynthesis. Mol. Plant, 2010, 3, 2-20.
15. Bucar, F. Phytoestrogens in plants: With special reference to isoflavones. In: Isoflavones; Chemistry, Analysis, Function, and Effects; Preedy, V.R., Ed.; RCS Publishing: Cambridge, 2013; Chapter 2, pp. 14-27.
16. Havsteen, B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Therapeut., 2002, 96, 67-202.
17. Sharma, S.K.; Kumar, S.; Chand, K.; Kathuria, A.; Gupta, A.; Jain, R. An update on natural occurrence and biological activity of chromones. Curr. Med. Chem., 2011, 18, 3825-3852.
18. Hughes, C.L. Jr. Phytochemical mimicry of reproductive hormones and modulation of herbivore fertility by phytoestrogens. Environ. Health Perspect., 1988, 78, 171-174.
19. Adams, N.R. Detection of the effects of phytoestrogens on sheep and cattle. J. Anim. Sci., 1995, 73, 1509-1515.
20. Knight, D.C.; Eden, J.A. Phytoestrogens-a short review. Maturitas, 1995, 22, 167-175.
21. Ingham, J.L. Naturally occurring isoflavonoids (1855-1981). Progr. Chem. Org. Natural Prod., 1983, 43, 1-266.
22. Ko, K.P. Isoflavones: Chemistry, analysis, functions and effects on health and cancer. Asian Pac. J. Cancer Prev., 2014, 15, 7001-7010.
23. Bhagwata, S.; Haytowitza, D.B.; Wasswa-Kintub, S.I.; Holdena, J.M. USDA develops a database for flavonoids to assess dietary intakes. Procedia Food Sci., 2013, (2), 81-86.
24. Dixon, R.A.; Ferreira, D. Molecules of interest. Genistein. Phytochemistry, 2002, 60, 205-211.
25. Szkudelska, K.; Nogowski, L. Genistein-a dietary compound inducing hormonal and metabolic changes. J. Steroid Biochem. Mol. Biol., 2007, 105, 37-45.
26. Banerjee, S.; Li, Y.; Wang, Z.; Sarkar, F.H. Multi-targeted therapy of cancer by genistein. Cancer Lett., 2008, 269, 226-242.
27. Rahman, S.; Islam, R.; Swaraz, A.M.; Ansari, A.; Parvez, A.K.; Paul, D.K. An insight on genistein as potential pharmacological and therapeutic agent. Asian Pac. J. Tropical Biomed., 2012, 2, S1924-S1937.
28. Spagnuolo, C.; Russo, G.L.; Orhan, I.E.; Habtemariam, S.; Daglia, M.; Sureda, A.; Nabavi, S.F.; Devi, K.P.; Loizzo, M.R.; Tundis, R.; Nabavi, S.M. Genistein and cancer: Current status, challenges, and future directions. Adv. Nutr., 2015, 6, 408-419.
29. Yearley, E.J.; Zhurova, E.A.; Zhurov, V.V.; Pinkerton, A.A. Binding of genistein to the estrogen receptor based on an experimental electron density study. J. Am. Chem. Soc., 2007, 129, 15013-15021.
30. Zhang, J.; Du, F.; Peng, B.; Lu, R.; Gao, H.; Zhou, Z. Structure, electronic properties, and radical scavenging mechanisms of daidzein, genistein, formononetin, and biochanin A: A density functional study. J. Mol. Structure: Theochem., 2010, 955, 1-6.
31. Wu, Q.; Wang, M.; Simon, J.E. Analytical methods to determine phytoestrogenic compounds. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2004, 812, 325-355.
32. Prokudina, E.A.; Havlicek, L.; Al-Maharik, N.; Lapcik, O.; Strnad, M.; Gruz, J. Rapid UPLC–ESI–MS/MS method for the analysis of isoflavonoids and other phenylpropanoids. J. Food Composition Anal., 2012, 26, 36-42.
33. Raju, K.S.R.; Kadian N.; Taneja, I.;Wahajuddin, M. Phytochemical analysis of isoflavonoids using liquid chromatography coupled with tandem mass spectrometry. Phytochem. Rev., 2015, 14, 469-498.
34. Balentine, D.A.; Dwyer, J.T.; Erdman, Jr, J.W.; Ferruzzi, M.G.; Gaine, P.C.; Harnly, J.M.; Kwik-Uribe, C.L. Recommendations on reporting requirements for flavonoids in research. Am. J. Clin. Nutr., 2015, 101, 1113-1125.
35. Wang, X. Structure, function, and engineering of enzymes in isoflavonoid biosynthesis. Funct. Integr. Genomics, 2011, 11, 13-22.
36. Preedy, V.R. Isoflavones: Chemistry, Analysis, Function and Effects; RCS Publishing: Cambridge, 2013.
37. Birt, D.F.; Hendrich, S.; Wang, W. Dietary agents in cancer prevention: Flavonoids and isoflavonoids. Pharmacol. Ther., 2001, 90, 157-177.
38. Le Marchand, L. Cancer preventive effects of flavonoids-a review. Biomed. Pharmacother., 2002, 56, 296-301.
39. Huntley, A.L.; Ernst, E. Soy for the treatment of perimenopausal symptoms-a systematic review. Maturitas, 2004, 47, 1-9.
40. Messina, M. Isoflavone intakes by Japanese were overestimated. Am. J. Clin. Nutr., 1995, 62, 645.
41. Knight, D.C.; Eden, J.A. A review of the clinical effects of phytoestrogens. Obstet. Gynecol., 1996, 87, 897-904.
42. Ye, Y.B.; Chen, A.L.; Lu, W.; Zhuo, S.Y.; Liu, J.; Guan, J.H.; Deng, W.P.; Fang, S.; Li, Y.B.; Chen, Y.M. Daidzein and genistein fail to improve glycemic control and insulin sensitivity in Chinese women with impaired glucose regulation: A double-blind, randomized, placebo-controlled trial. Mol. Nutr. Food Res., 2015, 59, 240-249.
43. Wuttke, W.; Jarry, H.; Seidlova-Wuttke, D. Isoflavones-safe food additives or dangerous drugs? Ageing Res. Rev., 2007, 6, 150-188
44. Marini, H.; Minutoli, L.; Polito, F.; Bitto, A.; Altavilla, D.; Atteritano, M.; Gaudio, A.; Mazzaferro, S.; Frisina, A.; Frisina, N.; Lubrano, C.; Bonaiuto, M.; D'anna, R.; Cannata, M.L.; Corrado, F.; Adamo, E.B.; Wilson, S.; Squadrito, F. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: A randomized trial. Ann. Intern. Med., 2007, 146, 839-847.
45. D'anna, R.; Cannata, M.L.; Atteritano, M.; Cancellieri, F.; Corrado, F.; Baviera, G.; Triolo, O.; Antico, F.; Gaudio, A.; Frisina, N.; Bitto, A.; Polito, F.; Minutoli, L.; Altavilla, D.; Marini, H.; Squadrito, F. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: A 1-year randomized, double-blind, placebo-controlled study. Menopause, 2007, 14, 648-655.
46. Atteritano, M.; Marini, H.; Minutoli, L.; Polito, F.; Bitto, A.; Altavilla, D.; Mazzaferro, S.; D'anna, R.; Cannata, M.L.; Gaudio, A.; Frisina, A.; Frisina, N.; Corrado, F.; Cancellieri, F.; Lubrano, C.; Bonaiuto, M.; Adamo, E.B.; Squadrito, F. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab., 2007, 92, 3068-3075.
47. Ding, M.; Franke, A.A.; Rosner, B.A.; Giovannucci, E.; Van Dam, R.M.; Tworoger, S.S.; Hu, F.B.; Sun, Q. Urinary isoflavonoids and risk of type 2 diabetes: A prospective investigation in US women. Br. J. Nutr., 2015, 114, 1694-1701.
48. Zaheer, K.; Akhtar, M.H. An updated review of dietary isoflavones: Nutrition, processing, bioavailability and impacts on human health. Crit. Rev. Food Sci. Nutr., 2015, in press, DOI 10.1080/10408398.2014.989958.
49. Kurzer, M.S. Hormonal effects of soy in premenopausal women and men. J. Nutr., 2002, 132, 570S-573S.
50. Rimbach, G.; Boesch-Saadatmandi, C.; Frank, J.; Fuchs, D.; Wenzel, U.; Daniel, H.; Hall, W.L.; Weinberg, P.D. Dietary isoflavones in the prevention of cardiovascular disease-a molecular perspective. Food Chem. Toxicol., 2008, 46, 1308-1319.
51. Wegrzyn, G.; Jakobkiewicz-Banecka, J.; Gabig-Ciminska, M.; Piotrowska, E.; Narajczyk, M.; Kloska, A.; Malinowska, M.; Dziedzic, D.; Golebiewska, I.; Moskot, M.; Wegrzyn, A. Genistein: A natural isoflavone with a potential for treatment of genetic diseases. Biochem. Soc. Trans., 2010, 38, 695-701.
52. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S.; Itoh, N.; Shibuya, M.; Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 1987, 262, 5592-5595.
53. Markovits, J.; Linassier, C.; Fosse, P.; Couprie, J.; Pierre, J.; Jacquemin-Sablon, A.; Saucier, J.M.; Le Pecq, J.B.; Larsen, A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res., 1989, 49, 5111-5117.
54. Matsuda, H.; Shimoda, H.; Morikawa, T.; Yoshikawa, M. Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): Structure-requirement of hydroxyanthraquinones for estrogenic activity. Bioorg. Med. Chem. Lett., 2001, 11, 1839-1842.
55. Gungor, T.; Chen, Y.; Golla, R.; Ma, Z.; Corte, J.R.; Northrop, J.P.; Bin, B.; Dickson, J.K.; Stouch, T.; Zhou, R.; Johnson, S.E.; Seethala, R.; Feyen, J.H. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators. J. Med. Chem., 2006, 49, 2440-2455.
56. Kostelac, D.; Rechkemmer, G.; Briviba, K. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J. Agric. Food Chem., 2003, 51, 7632-7635.
57. Pike, A.C.; Brzozowski, A.M.; Hubbard, R.E.; Bonn, T.; Thorsell, A.G.; Engstrom, O.; Ljunggren, J.; Gustafsson, J.A.; Carlquist, M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J., 1999, 18, 4608-4618.
58. Suetsugi, M.; Su, L.; Karlsberg, K.; Yuan, Y.C.; Chen, S. Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol. Cancer Res., 2003, 1, 981-991.
59. Dang, Z.C.; Audinot, V.; Papapoulos, S.E.; Boutin, J.A.; Lowik, C.W. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem., 2003, 278, 962-967.
60. Salam, N.K.; Huang, T.H.; Kota, B.P.; Kim, M.S.; Li, Y.; Hibbs, D.E. Novel PPAR-gamma agonists identified from a natural product library: A virtual screening, induced-fit docking and biological assay study. Chem. Biol. Drug Des., 2008, 71, 57-70.
61. Dodo, K.; Aoyama, A.; Noguchi-Yachide, T.; Makishima, M.; Miyachi, H.; Hashimoto, Y. Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development. Bioorg. Med. Chem., 2008, 16, 4272-4285.
62. Xu, L.; Ding, Y.; Catalona, W.J.; Yang, X.J.; Anderson, W.F.; Jovanovic, B.; Wellman, K.; Killmer, J.; Huang, X.; Scheidt, K.A.; Montgomery, R.B.; Bergan, R.C. MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J. Natl. Cancer Inst., 2009, 101, 1141-1155.
63. Traxler, P.; Trinks, U.; Buchdunger, E.; Mett, H.; Meyer, T.; Muller, M.; Regenass, U.; Rosel, J.; Lydon, N. [(Alkylamino)methyl]acrylophenones: Potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinase. J. Med. Chem., 1995, 38, 2441-2448.
64. Xie, H.Z.; Li, L.L.; Ren, J.X.; Zou, J.; Yang, L.; Wei, Y.Q.; Yang, S.Y. Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors. Bioorg. Med. Chem. Lett., 2009, 19, 1944-1949.
65. Rao, G.N. Protein tyrosine kinase activity is required for oxidant-induced extracellular signal-regulated protein kinase activation and c-fos and c-jun expression. Cell Signal, 1997, 9, 181-187.
66. Melani, R.; Tomati, V.; Galietta, L.J.; Zegarra-Moran, O. Modulation of cystic fibrosis transmembrane conductance regulator (CFTR) activity and genistein binding by cytosolic pH. J. Biol. Chem., 2010, 285, 41591-41596.
67. Afzal, I.; Cunningham, P.; Naftalin, R.J. Interactions of ATP, oestradiol, genistein and the anti-oestrogens, faslodex (ICI 182780) and tamoxifen, with the human erythrocyte glucose transporter, GLUT1. Biochem. J., 2002, 365, 707-719.
68. Vera, J.C.; Reyes, A.M.; Carcamo, J.G.; Velasquez, F.V.; Rivas, C.I.; Zhang, R.H.; Strobel, P.; Iribarren, R.; Scher, H.I.; Slebe, J.C. Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1. J. Biol. Chem., 1996, 271, 8719-8724.
69. Bazuine, M.; Van Den Broek, P.J.; Maassen, J.A. Genistein directly inhibits GLUT4-mediated glucose uptake in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun., 2005, 326, 511-514.
70. Imai, Y.; Tsukahara, S.; Asada, S.; Sugimoto, Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res., 2004, 64, 4346-4352.
71. Zhang, S.; Yang, X.; Morris, M.E. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol. Pharmacol., 2004, 65, 1208-1216.
72. Perez, M.; Real, R.; Mendoza, G.; Merino, G.; Prieto, J.G.; Alvarez, A.I. Milk secretion of nitrofurantoin, as a specific BCRP/ABCG2 substrate, in assaf sheep: Modulation by isoflavones. J. Vet. Pharmacol. Ther., 2009, 32, 498-502.
73. Okura, A.; Arakawa, H.; Oka, H.; Yoshinari, T.; Monden, Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Commun., 1988, 157, 183-189.
74. Bandele, O.J.; Osheroff, N. Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry, 2007, 46, 6097-6108.
75. Constantinou, A.; Mehta, R.; Runyan, C.; Rao, K.; Vaughan, A.; Moon, R. Flavonoids as DNA topoisomerase antagonists and poisons: Structure-activity relationships. J. Nat. Prod., 1995, 58, 217-225.
76. Bernard, F.X.; Sable, S.; Cameron, B.; Provost, J.; Desnottes, J.F.; Crouzet, J.; Blanche, F. Glycosylated flavones as selective inhibitors of topoisomerase IV. Antimicrob. Agents Chemother., 1997, 41, 992-998.
77. Chen, X.; Ung, C.Y.; Chen, Y. Can an in silico drug-target search method be used to probe potential mechanisms of medicinal plant ingredients? Nat. Prod. Rep., 2003, 20, 432-444.
78. Bloedon, L.T.; Jeffcoat, A.R.; Lopaczynski, W.; Schell, M.J.; Black, T.M.; Dix, K.J.; Thomas, B.F.; Albright, C.; Busby, M.G.; Crowell, J.A.; Zeisel, S.H. Safety and pharmacokinetics of purified soy isoflavones: Single-dose administration to postmenopausal women. Am. J. Clin. Nutr., 2002, 76, 1126-1137.
79. Setchell, K.D.; Brown, N.M.; Desai, P.; Zimmer-Nechemias, L.; Wolfe, B.E.; Brashear, W.T.; Kirschner, A.S.; Cassidy, A.; Heubi, J.E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr., 2001, 131, 1362S-1375S.
80. Kim, S.; Sohn, I.; Lee, Y.S.; Lee, Y.S. Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J. Nutr., 2005, 135, 33-41.
81. Li, Y.; Che, M.; Bhagat, S.; Ellis, K.L.; Kucuk, O.; Doerge, D.R.; Abrams, J.; Cher, M.L.; Sarkar, F.H. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia, 2004, 6, 354-363.
82. Li, Y.; Sarkar, F.H. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Lett., 2002, 186, 157-164.
83. Niculescu, M.D.; Pop, E.A.; Fischer, L.M.; Zeisel, S.H. Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J. Nutr. Biochem., 2007, 18, 380-390.
84. Pie, J.E.; Park, J.H.; Park, Y.H.; Ryu, Y.M.; Kim, K.N.; Suh, S.W.; Becker, K.G.; Cho-Chung, Y.S.; Kim, M.K. Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray. J. Nutr. Biochem., 2006, 17, 157-164.
85. Rice, L.; Handayani, R.; Cui, Y.; Medrano, T.; Samedi, V.; Baker, H.; Szabo, N.J.; Rosser, C.J.; Goodison, S.; Shiverick, K.T. Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells. J. Nutr., 2007, 137, 964-972.
86. Selvaraj, V.; Bunick, D.; Finnigan-Bunick, C.; Johnson, R.W.; Wang, H.; Liu, L.; Cooke, P.S. Gene expression profiling of 17 beta-estradiol and genistein effects on mouse thymus. Toxicol. Sci., 2005, 87, 97-112.
87. Lyou, S.; Hirano, E.; Tujioka, K.; Mawatari, Y.; Hayase, K.; Okuyama, S.; Yokogoshi, H. Dietary genistein affects brain protein synthesis rates in ovariectomized female rats. J. Nutr., 2002, 132, 2055-2058.
88. Velders, M.; Solzbacher, M.; Schleipen, B.; Laudenbach, U.; Fritzemeier, K.H.; Diel, P. Estradiol and genistein antagonize the ovariectomy effects on skeletal muscle myosin heavy chain expression via ER-beta mediated pathways. J. Steroid Biochem. Mol. Biol., 2010, 120, 53-59.
89. Takahashi, Y.; Lavigne, J.A.; Hursting, S.D.; Chandramouli, G.V.; Perkins, S.N.; Barrett, J.C.; Wang, T.T. Using DNA microarray analyses to elucidate the effects of genistein in androgen-responsive prostate cancer cells: Identification of novel targets. Mol. Carcinog., 2004, 41, 108-119.
90. Vanhees, K.; Coort, S.; Ruijters, E.J.; Godschalk, R.W.; Van Schooten, F.J.; Van Waalwijk Van Doorn-Khosrovani, B.S. Epigenetics: Prenatal exposure to genistein leaves a permanent signature on the hematopoietic lineage. FASEB J, 2011, 25, 797-807.
91. Day, J.K.; Bauer, A.M.; Desbordes, C.; Zhuang, Y.; Kim, B.E.; Newton, L.G.; Nehra, V.; Forsee, K.M.; Macdonald, R.S.; Besch-Williford, C.; Huang, T.H.; Lubahn, D.B. Genistein alters methylation patterns in mice. J. Nutr., 2002, 132, 2419S-2423S.
92. Farivar, R.S.; Gardner-Thorpe, J.; Ito, H.; Arshad, H.; Zinner, M.J.; Ashley, S.W.; Whang, E.E. The efficacy of tyrosine kinase inhibitors on human pancreatic cancer cell lines. J. Surg. Res., 2003, 115, 219-225.
93. Lavigne, J.A.; Takahashi, Y.; Chandramouli, G.V.; Liu, H.; Perkins, S.N.; Hursting, S.D.; Wang, T.T. Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: An oligo microarray study. Breast Cancer Res. Treat., 2008, 110, 85-98.
94. Mccue, P.; Shetty, K. Health benefits of soy isoflavonoids and strategies for enhancement: A review. Crit. Rev. Food Sci. Nutr., 2004, 44, 361-367.
95. Mccarty, M.F. Isoflavones made simple-Genistein’s agonist activity for the beta-type estrogen receptor mediates their health benefits. Med. Hypoth., 2006, 66, 1093-1114.
96. Masilamani, M.; Wei, J.; Sampson, H.A. Regulation of the immune response by soybean isoflavones. Immunol. Res., 2012, 54, 95-110.
97. Stanislaus von Kostanecki J.T. Berichte der deutschen chemischen Gesellschaft, 1912, 45, 1683-1707.
98. Seshadri, T.R. Biochemistry of natural pigments; (exclusive of haeme pigments and carotenoids). Ann. Rev. Biochem., 1951, 20, 487-512.
99. Edwards, A.M.; Howell, J.B. The chromones: History, chemistry and clinical development. A tribute to the work of Dr R.E.C. Altounyan. Clin. Exp. Allergy, 2000, 30, 756-774.
100. Gaspar, A.; Matos, M.J.; Garrido, J.; Uriarte, E.; Borges, F. Chromone: A valid scaffold in medicinal chemistry. Chem. Rev., 2014, 114, 4960-4992.
101. Levai, A. Synthesis of isoflavones. J. Heterocyclic Chem., 2004, 41, 449-460.
102. Tawfik, H.A.; Ewies, E.F.; El-Hamouly, W.S. Synthesis of chromones and their applications during the last ten years. Int. J. Res. Pharm. Chem., 2014, 4, 1046-1085.
103. Bradbury, R.B.; White, D.E. The chemistry of subterranean clover. Part I. Isolation of formononetin and genistein. J. Chem. Soc., 1951, (0), 3447-3449.
104. Venkataraman, K. Flavones and Isoflavones. Progr. Chem. Org. Nat. Prod., 1959, 17, 1-69.
105. Kagal, S.A.; Nair, P.M.; Venkataraman, K.A Synthesis of isoflavones by a modified Vilsmeier-Haack reaction. Tetrahedron Lett., 1962, 3, 593-597.
106. Pelter, A.; Foot, S. A new convenient synthesis of isoflavones. Synthesis, 1976, 5, 326.
107. Wähäla, K.; Hase, T.A. Expedient synthesis of polyhydroxyisoflavones. J. Chem. Soc., Perkin Trans. 1, 1991, (12), 3005-3008.
108. Chang, Y.C.; Nair, M.G.; Santell, R.C.; Helferich, W.G. Microwave-mediated synthesis of anticarcinogenic isoflavones from soybeans. J. Agric. Food Chem., 1994, 42, 1869-1871.
109. Balasubramanian, S.; Nair, M.G. An efficient “one- pot” synthesis of isoflavones. Synth. Commun., 2000, 30, 469-484.
110. Singh, H.; Pratap, R. A convenient one-pot synthesis of 7-hydroxy-isoflavones from resorcinol with substituted phenylacetic acids. Tetrahedron Lett., 2006, 47, 8161-8164.
111. Yadav, S.K. Process for the preparation of chromones, isoflavones and homoisoflavones using Vilsmeier reagent generated from phthaloyl dichloride and DMF. Int. J. Org. Chem., 2014, 4, 236-246.
112. Bass, R.J. Synthesis of chromones by cyclization of 2-hydroxyphenyl ketones with boron trifluoride-diethyl ether and methanesulphonyl chloride. J. Chem. Soc. Chem. Commun., 1976, (2), 78-79.
113. Kim, Y.W.; Brueggemeier, R.W. A convenient one-pot synthesis of 2-(alkylthio)isoflavones from deoxybenzoins using a phase transfer catalyst. Tetrahedron Lett., 2002, 43, 6113-6115.
114. Bhrara, S.C.; Jain, A.C.; Seshadri, T.R. Scope of isoflavone synthesis using 2'-benzyloxychalcone epoxides. Tetrahedron, 1965, 21, 963-967.
115. Farkas, L.; Gottsegen, A.; Nogradi, M.; Antus, S. Direct conversion of 2՛-hydroxychalcones into isoflavones using thallium(III) nitrate: Synthesis of (±)-sophorol and (±)-mucronulatol. J. Chem. Soc. Chem. Commun., 1972, (14), 825-826.
116. Farkas, L.; Gottsegen, A.; Noagradi, M.; Antus, S. Synthesis of sophorol, violanone, lonchocarpan, claussequinone, philenopteran, leiocalycin, and some other natural isoflavonoids by the oxidative rearrangement of chalcones with thallium(III) nitrate. J. Chem. Soc. Perkin Trans. 1, 1974, (0), 305-312.
117. Hoshino, Y.; Miyaura, N.; Suzuki, A. Novel synthesis of isoflavones by the palladium-catalyzed cross-coupling reaction of 3-bromochromones with arylboronic acids or its esters. Bull.Chem. Soc. Jpn, 1988, 61, 3008-3010.
118. Ding, K.; Wang, S. Efficient synthesis of isoflavone analogues via a Suzuki coupling reaction. Tetrahedron Lett., 2005, 46, 3707-3709.
119. Denis, J.D.S.; Gordon, J.S.; Carroll, V.M.; Priefer, R. Novel synthesis of the isoflavone genistein. Synthesis, 2010, 10, 1590-1592.
120. Selepe, M.A.; Van Heerden, F.R. Application of the Suzuki-Miyaura reaction in the synthesis of flavonoids. Molecules, 2013, 18, 4739-4765.
121. Kinoshita, T.; Ichinose, K.; Sankawa, U. One-step conversion of flavanones into isoflavones: A new facile biomimetic synthesis of isoflavones. Tetrahedron Lett., 1990, 31, 7355-7356.
122. 3]daidzein. Tetrahedron, 2004, 60, 1887-1893.
123. 3]isoflavones. J. Label. Compd. Radiopharm., 2010, 53, 95-103.
124. Li, S.R.; Chen, P.Y.; Chen, L.Y.; Lo, Y.F.; Tsai, I.L.; Wang, E.C. Synthesis of haginin E, equol, daidzein, and formononetin from resorcinol via an isoflavene intermediate. Tetrahedron Lett., 2009, 50, 2121-2123.
125. Dembitsky, V.M. Chemistry and biodiversity of the biologically active natural glycosides. Chem. Biodivers., 2004, 1, 673-781.
126. Blanchard, S.; Thorson, J.S. Enzymatic tools for engineering natural product glycosylation. Curr. Opin. Chem. Biol., 2006, 10, 263-271.
127. Gantt, R.W.; Peltier-Pain, P.; Thorson, J.S. Enzymatic methods for glyco(diversification/randomization) of drugs and small molecules. Nat. Prod. Rep., 2011, 28, 1811-1853.
128. Nicolaou, K.C.; Mitchell, H.J. Adventures in carbohydrate chemistry: New synthetic technologies, chemical synthesis, molecular design, and chemical biology. Angew. Chem. Int. Ed. Engl., 2001, 40, 1576-1624.
129. Demchenko, A.V. Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance; Wiley-VCH, Verlag GmbH & Co. KGaA.: Weinheim, 2008.
130. Jacobsson, M.; Malmberg, J.; Ellervik, U. Aromatic O-glycosylation. Carbohydr. Res., 2006, 341, 1266-1281.
131. Jensen, K.J. O-glycosylations under neutral or basic conditions. J. Chem. Soc. Perkin Trans. 1, 2002, (20), 2219-2233.
132. Conchie, J.; Levvy, G.A.; Marsh, C.A. Methyl and phenyl glycosides of the common sugars. Adv. Carbohydr. Chem. Biochem., 1957, 12, 157-187.
133. Zhong, W.; Boons, G.J. Thioglycosides in oligosachcharides sythesis, In: Handbook of Chemical Glycosylation: Advances in Stereoselectivity and Therapeutic Relevance; Demchenko, A.V., Ed.; Wiley-WCH: Weinheim, 2008; pp. 261-303.
134. Schmidt, R.R. New methods for the synthesis of glycosides and oligosachcarides: Are there alternatives to the Koenigs-Knorr method? Angew. Chem. Int. Ed. Engl., 1986, 25, 212-235.
135. Zhu, X.; Schmidt, R.R. New principles for glycoside bond formation. Angew. Chem. Int. Ed. Engl., 2009, 48, 1900-1934.
136. Yu, B.; Tao, H. Glycosyl trifluoroacatamidates. Part I. preparation and application as new glycosyl donors. Tetrahedron Lett., 2001, 42, 2405-2407.
137. Yu, B.; Sun, J. Glycosylation with glycosyl N-phenyltrifluoroacetimidates (PTFAI) and a perspective of the future development of new glycosylation methods. Chem. Commun. (Camb.), 2010, 46, 4668-4679.
138. Zemplen, G.; Farkas, L. Synthese des genistins. Chem. Ber., 1943, 76, 1110-1112.
139. Zemplen, G.; Farkas, L.; Bien, A. Synthese des ononins. Chem. Ber., 1944, 77, 452-457.
140. Lewis, P.T.; Katia, S.; Wähäla, K. The phase-transfer catalyzed synthesis of isoflavone O-glucosides. J. Chem. Soc. Perkin Trans. 1, 1998, (16), 2481-2484.
141. Lewis, P.T.; Wähäla, K. Regiospecific 4'-O- β-glucosidationof isoflavone O-glucosides. Tetrahedron Lett., 1998, 39, 9559-9562.
142. Shiozaki, M. Synthesis of 4-O-8-dihydroxyisoflavon-7-yl- α-D-arabinofuranoside. Tetrahedron: Asymmetry, 1999, 10, 1477-1482.
143. D-mannosyl fluoride. Tetrahedron Lett., 1989, 30, 6879-6882.
144. Watanabe, Y.; Shiozaki, M.; Kamegai, R. Synthesis and biological activity of 4',8-dihydroxyisoflavon-7-yl D-hexopyranosides. Carbohydr. Res., 2001, 335, 283-289.
145. Al-Maharik, N.; Botting, N.P. An efficient method for the glycosylation of isoflavones. Eur. J. Org. Chem., 2008, (33), 5622-5629.
146. Polkowski, K.; Popiolkiewicz, J.; Krzeczynski, P.; Ramza, J.; Pucko, W.; Zegrocka-Stendel, O.; Boryski, J.; Skierski, J.S.; Mazurek, A.P.; Grynkiewicz, G. Cytostatic and cytotoxic activity of synthetic genistein glycosides against human cancer cell lines. Cancer Lett., 2004, 203, 59-69.
147. Goux, C.; Lhotse, P.; Sinou, D. Synthesis of allylic aryl ethers via palladium(0)-catalyzed arylation of allylic carbonates. Synlett., 1992, (9), 725-727.
148. Lakhmiri, R.; Lhoste, P.; Kryczka, B.; Sinou, D. The use of 1-O-tosyl-glucopyranosie derivatives in glucoside synthesis. J. Carbohydr. Chem., 1993, 12, 223-235.
149. Sinou, D.; Frappa, I.; Lhoste, P.; Porwanski, S.; Kryczka, B. Stereoselective palladium(0)-mediated synthesis of 1,4-disaccharides. Tetrahedron Lett., 1995, 36, 1251-1254.
150. Rusin, A.; Gogler, A.; Glowala-Kosinska, M.; Bochenek, D.; Gruca, A.; Grynkiewicz, G.; Zawisza, J.; Szeja, W.; Krawczyk, Z. Unsaturated genistein disaccharide glycoside as a novel agent affecting microtubules. Bioorg. Med. Chem. Lett., 2009, 19, 4939-4943.
151. Szeja, W.; Puchalka, J.; Swierk, P.; Hendrich, A.B.; Grynkiewicz, G. Selective alkylation of genistein and daidzein. Chemistry & Biology Interface, 2013, 3, 95-106.
152. Rusin, A.; Zawisza-Puchalka, J.; Kujawa, K.; Gogler-Piglowska, A.; Wietrzyk, J.; Switalska, M.; Glowala-Kosinska, M.; Gruca, A.; Szeja, W.; Krawczyk, Z.; Grynkiewicz, G. Synthetic conjugates of genistein affecting proliferation and mitosis of cancer cells. Bioorg. Med. Chem., 2011, 19, 295-305.
153. Gruca, A.; Krawczyk, Z.; Szeja, W.; Grynkiewicz, G.; Rusin, A. Synthetic genistein glycosides inhibiting EGFR phosphorylation enhance the effect of radiation in HCT 116 colon cancer cells. Molecules, 2014, 19, 18558-18573.
154. Byczek, A.; Zawisza-Puchalka, J.; Gruca, A.; Papaj, K.; Grynkiewicz, G.; Rusin, M.; Szeja, W.; Rusin, A. Genistein derivatives regioisomerically substituted at 7-O- and 4 '-O- have different effect on the cell cycle. J. Chem., 2013, 2013, 1-12.
155. Talhi, O.; Silva, A.M.S. Advances in C-glycosylflavonoid Research. Curr. Organic Chemistry, 2012, 16, 859-896.
156. Simons, A.L.; Renouf, M.; Hendrich, S.; Murphy, P.A. Human gut microbial degradation of flavonoids: Structure-function relationships. J. Agric. Food Chem., 2005, 53, 4258-4263.
157. Xiao, J.; Muzashvili, T.S.; Georgiev, M.I. Advances in the biotechnological glycosylation of valuable flavonoids. Biotechnol. Adv., 2014, 32, 1145-1156.
158. Day, A.J.; Dupont, M.S.; Ridley, S.; Rhodes, M.; Rhodes, M.J.; Morgan, M.R.; Williamson, G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett., 1998, 436, 71-75.
159. Piskula, M.K.; Yamakoshi, J.; Iwai, Y. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett., 1999, 447, 287-291.
160. Andlauer, W.; Kolb, J.; Furst, P. Absorption and metabolism of genistin in the isolated rat small intestine. FEBS Lett., 2000, 475, 127-130.
161. Walgren, R.A.; Lin, J.T.; Kinne, R.K.; Walle, T. Cellular uptake of dietary flavonoid quercetin 4'-beta-glucoside by sodium-dependent glucose transporter SGLT1. J. Pharmacol. Exp. Ther., 2000, 294, 837-843.
162. Szeja, W.; Swierk, P.; Rusin, A.; Grynkiewicz, G.; Papaj, K. An approach to C-glycosidic conjugates of isoflavones. Heterocycl. Commun., 2013, 19, 133-138.
163. Szeja, W.; Grynkiewicz, G.; Bieg, T.; Swierk, P.; Byczek, A.; Papaj, K.; Kitel, R.; Rusin, A. Synthesis and cytotoxicity of 2,3-enopyranosyl C-linked conjugates of genistein. Molecules, 2014, 19, 7072-7093.
164. Jesus, A.R.; Dias, C.; Matos, A.M.; De Almeida, R.F.; Viana, A.S.; Marcelo, F.; Ribeiro, R.T.; Macedo, M.P.; Airoldi, C.; Nicotra, F.; Martins, A.; Cabrita, E.J.; Jimenez-Barbero, J.; Rauter, A.P. Exploiting the therapeutic potential of 8-beta-d-glucopyranosylgenistein: Synthesis, antidiabetic activity, and molecular interaction with islet amyloid polypeptide and amyloid beta-peptide (1-42). J. Med. Chem., 2014, 57, 9463-9472.
165. Gadgeel, S.M.; Ali, S.; Philip, P.A.; Wozniak, A.; Sarkar, F.H. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer, 2009, 115, 2165-2176.
166. Junior, C.O.; Castro, S.B.; Pereira, A.A.; Alves, C.C.; Oliveira, E.E.; Rego, R.T.; Ferreira, A.P.; De Almeida, M.V. Synthesis of genistein coupled with sugar derivatives and their inhibitory effect on nitric oxide production in macrophages. Eur. J. Med. Chem., 2014, 85, 615-620.
167. Stancanelli, R.; Mazzaglia, A.; Tommasini, S.; Calabro, M.L.; Villari, V.; Guardo, M.; Ficarra, P.; Ficarra, R. The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: A spectroscopic investigation with implications in the pharmaceutical analysis. J. Pharm. Biomed. Anal., 2007, 44, 980-984.
168. Li, H.Q.; Xue, J.Y.; Shi, L.; Gui, S.Y.; Zhu, H.L. Synthesis, crystal structure and antimicrobial activity of deoxybenzoin derivatives from genistein. Eur. J. Med. Chem., 2008, 43, 662-667.
169. Zhang, L.N.; Cao, P.; Tan, S.H.; Gu, W.; Shi, L.; Zhu, H.L. Synthesis and antimicrobial activities of 7-O-modified genistein derivatives. Eur. J. Med. Chem., 2008, 43, 1543-1551.
170. Sroda, K.; Michalak, K.; Maniewska, J.; Grynkiewicz, G.; Szeja, W.; Zawisza, J.; Hendrich, A.B. Genistein derivatives decrease liposome membrane integrity--calcein release and molecular modeling study. Biophys. Chem., 2008, 138, 78-82.
171. Chu, J.; Wu, X.; Li, B.; He, B. Efficient glucosylation of flavonoids by organic solvent-tolerant Staphylococcus saprophyticus CQ16 in aqueous hydrophilic media. J. Molecular Catalysis B, Enzymatic, 2014, 99, 8-13.
172. Li, D.; Roh, S.A.; Shim, J.H.; Mikami, B.; Baik, M.Y.; Park, C.S.; Park, K.H. Glycosylation of genistin into soluble inclusion complex form of cyclic glucans by enzymatic modification. J. Agric. Food Chem., 2005, 53, 6516-6524.
173. Grynkiewicz, G.; Szeja, W. Synthetic glycosides and glycoconjugates of low molecular weight natural products. Curr. Pharm. Des., 2016, 22, 1592-1627.
174. Cherblanc, F.L.; Davidson, R.W.; Di Fruscia, P.; Srimongkolpithak, N.; Fuchter, M.J. Perspectives on natural product epigenetic modulators in chemical biology and medicine. Nat. Prod. Rep., 2013, 30, 605-624.